Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analyses.

Lowe GD.

J Thromb Haemost. 2012 Oct;10(10):2186-8. doi: 10.1111/j.1538-7836.2012.04882.x. No abstract available.

PMID:
22888854
[PubMed - indexed for MEDLINE]
2.

Etiology of venous thrombosis: the need for small original studies.

Rosendaal FR.

J Thromb Haemost. 2012 Oct;10(10):2189-90. doi: 10.1111/j.1538-7836.2012.04881.x. No abstract available.

PMID:
23025411
[PubMed - indexed for MEDLINE]
3.

Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.

El-Galaly TC, Kristensen SR, Overvad K, Steffensen R, Tjønneland A, Severinsen MT.

J Thromb Haemost. 2012 Oct;10(10):2191-3. doi: 10.1111/j.1538-7836.2012.04772.x. No abstract available.

PMID:
22577971
[PubMed - indexed for MEDLINE]
4.

Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.

Gadelha T, Roldán V, Lecumberri R, Trujillo-Santos J, del Campo R, Poggio R, Monreal M; RIETE Investigators.

Thromb Res. 2010 Oct;126(4):283-6. doi: 10.1016/j.thromres.2010.06.019. Epub 2010 Jul 13.

PMID:
20627204
[PubMed - indexed for MEDLINE]
5.

Oral contraceptives, ABO blood types and thromboembolism.

Ambrus JL.

CMAJ. 2013 Nov 19;185(17):1526. doi: 10.1503/cmaj.113-2148. No abstract available.

PMID:
24247436
[PubMed - indexed for MEDLINE]
6.

Genetic susceptibility, smoking, obesity and risk of venous thromboembolism.

Severinsen MT, Overvad K, Johnsen SP, Dethlefsen C, Madsen PH, Tjønneland A, Kristensen SR.

Br J Haematol. 2010 Apr;149(2):273-9. doi: 10.1111/j.1365-2141.2010.08086.x. Epub 2010 Feb 8.

PMID:
20148880
[PubMed - indexed for MEDLINE]
7.

High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients.

Gary T, Hafner F, Froehlich H, Stojakovic T, Scharnagl H, Pilger E, Brodmann M.

Acta Haematol. 2010;124(4):214-7. doi: 10.1159/000321530. Epub 2010 Nov 12. No abstract available.

PMID:
21071930
[PubMed - indexed for MEDLINE]
8.

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR.

Ann Intern Med. 1998 Jan 1;128(1):15-20.

PMID:
9424976
[PubMed - indexed for MEDLINE]
9.

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.

Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE.

Blood. 2009 May 21;113(21):5298-303. doi: 10.1182/blood-2008-11-190389. Epub 2009 Mar 10.

PMID:
19278955
[PubMed - indexed for MEDLINE]
Free Article
10.

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR.

Ann Intern Med. 2001 Sep 4;135(5):322-7.

PMID:
11529695
[PubMed - indexed for MEDLINE]
11.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
[PubMed - indexed for MEDLINE]
12.

Risk factors and clinical presentation of venous thromboembolism according to the age of relatives of patients with factor V Leiden.

Couturaud F, Leroyer C, Mottier D; Groupe dEtude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Apr;99(4):793-4. doi: 10.1160/TH07-12-0720. No abstract available.

PMID:
18392344
[PubMed - indexed for MEDLINE]
13.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C.

Chest. 2009 Dec;136(6):1537-45. doi: 10.1378/chest.09-0757. Epub 2009 Jul 10.

PMID:
19592474
[PubMed - indexed for MEDLINE]
14.

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.

Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.

PMID:
18796457
[PubMed - indexed for MEDLINE]
15.

[Venous thromboembolic events in surgery: a role of genetic disorders].

Aliev MA, Mierbekov EM, Sviatova GS, Artykbaev ZhT, Kalyshev RS.

Anesteziol Reanimatol. 2008 Jan-Feb;(1):71-3. Russian. No abstract available.

PMID:
18368843
[PubMed - indexed for MEDLINE]
16.

Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.

Chaireti R, Jennersjö C, Lindahl TL.

Thromb Res. 2009 Jun;124(2):178-84. doi: 10.1016/j.thromres.2008.12.033. Epub 2009 Feb 20.

PMID:
19232683
[PubMed - indexed for MEDLINE]
17.

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.

Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB.

N Engl J Med. 2000 Feb 10;342(6):374-80.

PMID:
10666427
[PubMed - indexed for MEDLINE]
Free Article
18.

Factor V Leiden: a case study and review.

Slusher KB.

Dimens Crit Care Nurs. 2010 Jan-Feb;29(1):6-10. doi: 10.1097/DCC.0b013e3181be4985. Review.

PMID:
20010186
[PubMed - indexed for MEDLINE]
19.

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

Canonico M, Olié V, Carcaillon L, Tubert-Bitter P, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group.

Thromb Haemost. 2008 Jan;99(1):246-8. doi: 10.1160/TH07-09-0536. No abstract available.

PMID:
18217166
[PubMed - indexed for MEDLINE]
20.

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

Sveinsdottir SV, Saemundsson Y, Isma N, Gottsäter A, Svensson PJ.

Thromb Res. 2012 Sep;130(3):467-71. doi: 10.1016/j.thromres.2012.03.020. Epub 2012 Apr 17.

PMID:
22512897
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk